Albion backs healthcare software firm MyMeds&Me
Albion Ventures has invested ТЃ2m in British healthcare software-as-a-service (SaaS) business MyMeds&Me.
The new capital will be used to develop the company's software platform and fund its commercial roll-out.
Company
MyMeds&Me is a London-based software company, providing a web-based solution for real-time feedback of pharmaceuticals from both patients and healthcare professionals.
The SaaS business was founded by Stephen Powell, Andrew Rut and Trevor Gibbs in 2011. MyMeds&Me is working with pharma companies, as well as other players in the sector with interest in consumer data. The company is not profitable yet.
People
Albion's Andrew Elder, partner in the healthcare team, led the investment for the GP. Andrew Rut and Stephen Powell are CEO and chairman of MyMeds&Me respectively.
Advisers
Equity - Bird&Bird (Legal); Crowe CLark Whitehill (Financial due diligence); Intuitus (IT due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








